Ischemia-free liver transplantation improves the prognosis of recipients using functionally marginal liver grafts

키워드

참고문헌 (44)

1. Terrault NA, "Liver transplantation 2023 : Status report, current and future challenges", Clin Gastroenterol Hepatol, 21, pp.2150~2166 (2023)
2. Kim WR, "Liver", Am J Transplant, 16(Suppl 2), pp.69~98 (2016)
3. Bruzzone P, "A preliminary European Liver and Intestine Transplant Association-European Liver Transplant Registry study on informed recipient consent and extended criteria liver donation", Transplant Proc, 45, pp.2613~2615 (2013)
4. Vodkin I, "Extended criteria donors in liver transplantation", Clin Liver Dis, 21, pp.289~301 (2017)
5. Lin Y, "Assessing donor liver quality and restoring graft function in the era of extended criteria donors", J Clin Transl Hepatol, 11, pp.219~230 (2023)
6. Figueras J, "The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis", Transplantation, 61, pp.410~413 (1996)
7. Nemes B, "Extended criteria donors in liver transplantation Part I : reviewing the impact of determining factors", Expert Rev Gastroenterol Hepatol, 10, pp.827~839 (2016)
8. He X, "The first case of ischemia-free organ transplantation in humans : A proof of concept", Am J Transplant, 18, pp.737~744 (2018)
9. Guo Z, "A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease", J Hepatol, 79, pp.394~402 (2023)
10. Chen M, "Application of ischaemia-free liver transplantation improves prognosis of patients with steatotic donor livers-a retrospective study", Transpl Int, 34, pp.1261~1270 (2021)
11. Guo Z, "Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantation", Clin Transl Med, 12, pp.e546~ (2022)
12. Tang Y, "Ischemicfree liver transplantation reduces the recurrence of hepatocellular carcinoma after liver transplantation", Front Oncol, 11, pp.773535~ (2021)
13. Laing RW, "Viability testing and transplantation of marginal livers(VITTAL)using normothermic machine perfusion : study protocol for an open-label, non-randomised, prospective, singlearm trial", BMJ Open, 7, pp.e017733~ (2017)
14. Chen L, "Copper homeostasis and cuproptosis in health and disease", Signal Transduct Target Ther, 7, pp.378~ (2022)
15. Sun X, "PANoptosis : Mechanisms, biology, and role in disease", Immunol Rev, 321, pp.246~262 (2024)
16. Subramanian A, "Gene set enrichment analysis : a knowledge-based approach for interpreting genome-wide expression profiles", Proc Natl Acad Sci U S A, 102, pp.15545~15550 (2005)
17. Liberzon A, "The Molecular Signatures Database(MSigDB)hallmark gene set collection", Cell Syst, 1, pp.417~425 (2015)
18. Hemani G, "The MR-Base platform supports systematic causal inference across the human phenome", Elife, 7, pp.e34408~ (2018)
19. Kolberg L, "g : Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping(2023 update)", Nucleic Acids Res, 51, pp.W207~W212 (2023)
20. Zhou Y, "Metascape provides a biologist-oriented resource for the analysis of systems-level datasets", Nat Commun, 10, pp.1523~ (2019)
21. Aran D, "Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage", Nat Immunol, 20, pp.163~172 (2019)
22. Zhang X, "Cell-Marker : a manually curated resource of cell markers in human and mouse", Nucleic Acids Res, 47, pp.D721~D728 (2019)
23. Chouchani ET, "Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS", Nature, 515, pp.431~435 (2014)
24. Nasralla D, "A randomized trial of normothermic preservation in liver transplantation", Nature, 557, pp.50~56 (2018)
25. Dutkowski P, "Novel shortterm hypothermic oxygenated perfusion(HOPE)system prevents injury in rat liver graft from non-heart beating donor", Ann Surg, 244, pp.968~976 (2006)
26. de Rougemont O, "One hour hypothermic oxygenated perfusion(HOPE)protects nonviable liver allografts donated after cardiac death", Ann Surg, 250, pp.674~683 (2009)
27. Schlegel A, "Hypothermic Oxygenated Perfusion(HOPE)downregulates the immune response in a rat model of liver transplantation", Ann Surg, 260, pp.931~937 (2014)
28. Guarrera JV, "Hypothermic machine preservation in human liver transplantation : the first clinical series", Am J Transplant, 10, pp.372~381 (2010)
29. van Rijn R, "Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death", Br J Surg, 104, pp.907~917 (2017)
30. van Rijn R, "Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers", Liver Transpl, 24, pp.655~664 (2018)
31. van Rijn R, "Hypothermic machine perfusion in liver transplantation-A randomized trial", N Engl J Med, 384, pp.1391~1401 (2021)
32. Bergsbaken T, "Pyroptosis : host cell death and inflammation", Nat Rev Microbiol, 7, pp.99~109 (2009)
33. Kadono K, "Myeloid Ikaros-SIRT1 signaling axis regulates hepatic inflammation and pyroptosis in ischemia-stressed mouse and human liver", J Hepatol, 76, pp.896~909 (2022)
34. He WT, "Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion", Cell Res, 25, pp.1285~1298 (2015)
35. Lucas-Ruiz F, "Emerging role of NLRP3 inflammasome and pyroptosis in liver transplantation", Int J Mol Sci, 23, pp.14396~ (2022)
36. Liu H, "New insights in mechanisms and therapeutics for short-and long-term impacts of hepatic ischemia reperfusion injury post liver transplantation", Int J Mol Sci, 22, pp.8210~ (2021)
37. Kadono K, "SIRT1 regulates hepatocyte programmed cell death via GSDME-IL18 axis in human and mouse liver transplantation", Cell Death Dis, 14, pp.762~ (2023)
38. Harmon C, "Natural killer cells and liver transplantation : Orchestrators of rejection or tolerance?", Am J Transplant, 16, pp.751~757 (2016)
39. Huang M, "Natural killer cells in hepatic ischemia-reperfusion injury", Front Immunol, 13, pp.870038~ (2022)
40. Lu D, "Dynamic immune cell profiling identified natural killer cell shift as the key event in early allograft dysfunction after liver transplantation", Cell Prolif, 57, pp.e13568~ (2024)
41. Pagano D, "Liver perfusate natural killer cells from deceased brain donors and association with acute cellular rejection after liver transplantation : A time-to-rejection analysis", Transplantation, 103, pp.371~380 (2019)
42. Kim SH, "Interleukin-32 : a cytokine and inducer of TNFalpha", Immunity, 22, pp.131~142 (2005)
43. Gorvel L, "Dendritic cellderived IL-32α : A novel inhibitory cytokine of NK cell function", J Immunol, 199, pp.1290~1300 (2017)
44. Schenk M, "NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy", Nat Med, 18, pp.555~563 (2012)

관련 논문AI추천